Evidence map›Paper›PMID 30030883›Full record

ArticleJournal of cellular and molecular medicine2018

Collagen peptide modified carboxymethyl cellulose as both antioxidant drug and carrier for drug delivery against retinal ischaemia/reperfusion injury.

Hua Mu, Yeqing Wang, Haiying Wei, Hong Lu, Zhuolei Feng, Hongmin Yu, Yue Xing, Haijing Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Retinal ischemia-reperfusion injury and pretreatment withInternational journal of ophthalmology · 2024
    Article
  4. Article
  5. Review
  6. Recent Progress on Cellulose-Based Ionic Compounds for Biomaterials.Advanced materials (Deerfield Beach, Fla.) · 2021
    Review
  7. Review
  8. Review
  9. Article
  10. Roles of Exosomes in Ocular Diseases.International journal of nanomedicine · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hua MuDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yeqing WangDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.ORCID 0000-0003-1067-8651
Haiying WeiDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Hong LuDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Zhuolei FengDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Hongmin YuDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Yue XingDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Haijing WangDepartment of Ophthalmology, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress can cause injury in retinal endothelial cells. Carboxymethyl cellulose modified with collagen peptide (CMCC) is of a distinct antioxidant capacity and potentially a good drug carrier. In this study, the protective effects of CMCC against H

Indexed as

AnimalsAntioxidantsApoptosisCarboxymethylcellulose SodiumCatalaseCollagenDrug CarriersDrug Delivery SystemsEndothelial CellsHumansHydrogen PeroxideInflammationInterleukin-10Oxidative StressPeptidesRatsAntioxidantsCarboxymethylcellulose SodiumCatalaseCollagenDrug CarriersHydrogen PeroxideInterleukin-10PeptidesReactive Oxygen Speciesantioxidant carrierdrug deliveryIL-10retinal ischaemia/reperfusion injury

Identifiers

PMID30030883
PMCPMC6156360
OpenAlexW2883469745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.